Trials / Recruiting
RecruitingNCT03770936
Effect of Some Drugs on Liver Fibrosis
Clinical Study Evaluating the Efficacy of Renin Angiotensin System Inhibitors on the Extent of Liver Fibrosis in Patients With Chronic Hepatitis C
- Status
- Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 45 (estimated)
- Sponsor
- Sherief Abd-Elsalam · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
Effect of Some Drugs on Liver Fibrosis
Detailed description
The study aimed at evaluating the effect of Some Drugs on Liver Fibrosis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Candesartan | Candesartan 8 mg/day |
| DRUG | Ramipril | ramipril 1.25 mg/day |
Timeline
- Start date
- 2018-10-01
- Primary completion
- 2026-10-01
- Completion
- 2027-11-01
- First posted
- 2018-12-10
- Last updated
- 2018-12-10
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03770936. Inclusion in this directory is not an endorsement.